Suppr超能文献

不进行长期全身肝素化的视网膜中央动脉阻塞选择性溶栓治疗。

Selective thrombolysis of central retinal artery occlusion without long-term systemic heparinization.

作者信息

Wirostko W J, Pulido J S, Hendrix L E

机构信息

The Eye Institute, Medical College of Wisconsin, Milwaukee 53226-4812, USA.

出版信息

Surg Neurol. 1998 Nov;50(5):408-10. doi: 10.1016/s0090-3019(97)00338-8.

Abstract

BACKGROUND

A central retinal artery occlusion is a potentially blinding retinal vascular event with no effective treatment regimen available. Recently, a few reports have described improved vision in eyes with central retinal artery occlusions after selective fibrinolytic therapy followed by long-term systemic anticoagulation. Acceptance of this treatment, however, has been hampered by a paucity of confirmatory reports and its potential for producing serious hemorrhagic complications. Our report independently confirms the beneficial effects of selective thrombolysis, even with the use of only short-term, post-procedure systemic heparinization.

METHODS

A case report of selective fibrinolysis of an occluded central retinal artery using urokinase infusion into the ophthalmic artery followed with only 12 h of systemic heparinization is described.

RESULTS

A 65-year-old man presenting with a central retinal artery occlusion of less than 4-h duration enjoyed an improvement of vision from counting-fingers acuity to 20/20 after selective fibrinolysis with urokinase and only 12 h of systemic heparinization. No hemorrhagic or thrombotic complications occurred.

CONCLUSIONS

Selective thrombolysis with urokinase followed by short-term systemic heparinization can effectively treat a central retinal artery occlusion. Whereas the authors acknowledge that a single case does not prove that short-term heparinization is better than long-term heparinization, it does show that the latter is not always required.

摘要

背景

视网膜中央动脉阻塞是一种可能导致失明的视网膜血管事件,目前尚无有效的治疗方案。最近,有一些报告描述了在选择性纤维蛋白溶解疗法并长期全身抗凝治疗后,视网膜中央动脉阻塞患者的视力有所改善。然而,由于缺乏确凿的报告以及该疗法可能引发严重出血并发症,这种治疗方法的接受度受到了阻碍。我们的报告独立证实了选择性溶栓的有益效果,即使仅使用术后短期全身肝素化。

方法

描述了一例通过向眼动脉注入尿激酶对阻塞的视网膜中央动脉进行选择性纤维蛋白溶解,并仅进行12小时全身肝素化的病例报告。

结果

一名65岁男性,视网膜中央动脉阻塞持续时间不到4小时,在接受尿激酶选择性纤维蛋白溶解和仅12小时全身肝素化治疗后,视力从数指视力提高到了20/20。未发生出血或血栓形成并发症。

结论

尿激酶选择性溶栓后短期全身肝素化可有效治疗视网膜中央动脉阻塞。虽然作者承认单个病例不能证明短期肝素化优于长期肝素化,但确实表明并非总是需要长期肝素化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验